Rett syndrome: review of biological abnormalities

Area of Science:

• Neuroscience
• Genetics
• Pediatric Neurology

Background:

• Rett syndrome (RS) is a rare, sporadic neurodevelopmental disorder predominantly affecting females.
• It involves developmental slowing, loss of acquired skills, and distinctive motor and behavioral features.
• Historically considered X-linked, new genetic insights have emerged.

Purpose of the Study:

• To review the clinical manifestations, genetic basis, and neuropathological findings in Rett syndrome.
• To explore neurometabolic and neuroimaging data related to RS.
• To discuss ongoing research into MECP2 gene mutations and their effects.

Main Methods:

• Review of clinical studies, genetic linkage analyses, and mutation identification in the MECP2 gene.
• Neuropathological and electrophysiological assessments.
• Analysis of neurometabolic factors (neurotransmitters, growth factors) and neuroimaging (MRI, PET).

Main Results:

• Mutations in the MECP2 gene, encoding methyl cytosine-binding protein 2, are identified in a significant proportion of RS cases.
• Studies reveal alterations in neurotransmitter levels (dopamine, serotonin) and nerve growth factors.
• Neuroimaging studies provide insights into brain structure and function in RS patients.

Conclusions:

• MECP2 gene mutations are central to the pathophysiology of Rett syndrome.
• Further research is crucial for understanding the molecular mechanisms and developing targeted therapies.
• Comprehensive analysis of clinical, genetic, and imaging data aids in characterizing RS progression and heterogeneity.